PFIZER’s Xeljanz (tofacitinib
citrate) will be listed on the
PBS from 01 Oct as a new
oral treatment alternative for
adults with moderate to severe
rheumatoid arthritis who have
had an inadequate response to
conventional disease-modifying
antirheumatic drugs (DMARDs).The above article was sent to subscribers in Pharmacy Daily's issue from 23 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Sep 15
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.